The efficacy of antidepressants is positively correlated with their modulation effect at the BDNF expression [49], and both selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) normalize BDNF expression in MDD patients [50,51]. Here, BDNF is linked to major depressive disorder.